Cellectar Biosciences CLRB
NASDAQ CLRB
$1.86 +0.02 (+1.08%)
As of: Oct 1, 2026 · 2:08 PM EDT

Cellectar Biosciences (CLRB) Other Operating Expenses (2010 - 2018)

Updated

Cellectar Biosciences (CLRB) reported Other Operating Expenses of $1.68 million for Q4 2018.

Analysis

Cellectar Biosciences (CLRB) Other Operating Expenses (2010 - 2018) Analysis & Trends

Dating back to Q4 2010, Cellectar Biosciences' Other Operating Expenses record includes 4 quarters.

  • The Q4 2018 figure ranks as the lowest quarterly Other Operating Expenses since Q2 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cellectar Biosciences 22.51 Mn 22.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.68 Mn
Jun 30, 2011 495,773.00
Mar 31, 2011 250,434.00
Dec 31, 2010 52,925.00
API Access

Cellectar Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CLRB&period=max&api_key=YOUR_API_KEY